Kuraray Reinforces Nanomaterial Product Safety with Continuous Cross-Divisional Assessments, Critical Review Committee Set to Convene in 2025

Kuraray Japan

Overview

The Kuraray Group is proactively addressing the safety of nanomaterial-containing products through a rigorous, company-wide assessment system. Led by its Corporate Sustainability Division, a specialized evaluation committee, operating under the “Critical Matters Assessment Committee Regulations,” thoroughly vets new product developments and market launches for safety, with reviews continuing into 2025. This commitment highlights Kuraray’s dedication to early risk identification, product safety, and sustainable innovation, positioning it ahead of evolving global nanomaterial regulations.

In Depth

Background

Nanotechnology continues to drive innovation across diverse sectors, including high-performance materials, electronics, and medicine. However, the unique properties of nanomaterials, stemming from their minute size and high surface area, can lead to distinct physicochemical characteristics and biological interactions compared to bulk materials. This raises legitimate concerns regarding their potential environmental and human health impacts, leading to a global surge in regulatory scrutiny and societal interest in nanomaterial safety. Companies developing such advanced materials face an imperative to ensure product safety from conception to market.

Key Findings

The Kuraray Group has established and continuously implements a robust, cross-divisional safety assessment system for products and developments containing nanomaterials. This system operates under the “Critical Matters Assessment Committee Regulations,” spearheaded by the Corporate Sustainability Division. Before product development and market launch, an evaluation committee rigorously assesses and verifies the safety of these advanced materials. In a testament to this ongoing commitment, the committee has confirmed its review of issues related to the development and commercialization of products falling under these regulations in 2025.

Technical/Clinical Details

Kuraray’s safety review process is built upon a profound understanding of nanomaterial characteristics and their potential risks. Recognizing that nanomaterials can exhibit distinct physicochemical properties and biological interactions, the company’s evaluation committee employs a multifaceted approach to assess product safety. This includes:

• Detailed Analysis of Physicochemical Properties: Thorough examination of parameters such as particle size distribution, morphology, surface area, chemical composition, and crystal structure.
• Manufacturing Process Evaluation: Assessment of potential nanoparticle generation, exposure risks, and the efficacy of control measures during production.
• Lifecycle Impact Assessment: Comprehensive evaluation of potential environmental release and human exposure throughout the product’s entire lifecycle, encompassing usage, disposal, and recycling.

To support these assessments, the committee leverages a range of scientific data, including existing toxicity data, results from in vitro assays, in silico predictive models, and, where appropriate, in vivo studies. Based on this robust scientific evidence, the committee determines the adequacy of risk management measures and ensures compliance with regulatory requirements. This meticulous process enables Kuraray to identify safety concerns early, integrate them into product design and manufacturing methods, and ultimately deliver high-performance yet demonstrably safe products to the market.

Industry Context

While nanotechnology propels innovation, the global landscape for nanomaterial safety regulations and public awareness is rapidly intensifying. Jurisdictions worldwide are introducing more stringent legal requirements for nanomaterial characterization and risk management, exemplified by amendments to the European Union’s REACH regulation and the introduction of new nanomaterial frameworks in Canada. Kuraray, as a leading Japanese chemical manufacturer, demonstrates a strong commitment to corporate social responsibility (CSR) by proactively establishing and continuously operating such a cross-divisional safety review system. This initiative positions Kuraray ahead of international regulatory trends and serves as an exemplary model for “responsible innovation” in advanced materials development.

Future Outlook

Kuraray’s cross-divisional safety assessment framework for nanomaterials will remain a critical pillar of its new product development strategy. As nanotechnology advances, leading to more complex nanomaterials and sophisticated applications, this evaluation process will require continuous evolution and enhancement. Significant improvements are anticipated through the integration of advanced safety assessment methodologies, including predictive toxicology, digital twins, and AI/machine learning, which are expected to boost both efficiency and accuracy. Kuraray’s proactive engagement in this domain is poised to contribute to bridging data gaps in nanomaterial safety, fostering best practices across the industry, and ultimately ensuring consumer and environmental protection, thereby supporting the sustainable development of nanotechnology.